KG
Karapureddy Gnana Simhanatha Reddy
About Karapureddy Gnana Simhanatha Reddy
Data last updated:
Karapureddy Gnana Simhanatha Reddy is a Director at Asclepiuss Pharma Traders Private Limited (since 2021) and Designated Partner at Neuravon Technology Research Institutions Llp (since 2025). The companies operate in Home Appliances. The largest current company by reported revenue is Asclepiuss Pharma Traders Private Limited at ₹1.92 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Asclepiuss Pharma Traders Private Limited U52100TG2021PTC156850 | Director | 11 Nov 2021 | 2021 | ₹1.92 Cr (FY 2025) | Active |
| Designated Partner | 17 Nov 2025 | 2025 | Active |
Board colleagues of Karapureddy Gnana Simhanatha Reddy
| Name | DIN | Company | Designation |
|---|---|---|---|
| Padmaja Karapureddy | 06718401 | Asclepiuss Pharma Traders Private Limited | Director |
| Latha Chinnireddy | 11384963 | Neuravon Technology Research Institutions Llp | Designated Partner |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Karapureddy Gnana Simhanatha Reddy
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Karapureddy Gnana Simhanatha Reddy
Karapureddy Gnana Simhanatha Reddy currently holds 2 directorships: Asclepiuss Pharma Traders Private Limited (Director, since 11 Nov 2021, revenue ₹1.92 Cr (FY 2025)); Neuravon Technology Research Institutions Llp (Designated Partner, since 17 Nov 2025).
Karapureddy Gnana Simhanatha Reddy was first appointed on 11 Nov 2021 as Director at Asclepiuss Pharma Traders Private Limited. The most recent appointment on record is 17 Nov 2025 at Neuravon Technology Research Institutions Llp.
The current boards of Karapureddy Gnana Simhanatha Reddy's companies include Padmaja Karapureddy (Asclepiuss Pharma Traders Private Limited), Latha Chinnireddy (Neuravon Technology Research Institutions Llp).